ClinicalTrials.govpublic full text
Tirellizumab+Anlotinib VS Anlotinib for MSS-type CRC
colon cancer, immunotherapy
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 245526
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.